Evidence map›Paper›PMID 36056843›Full record

ArticlePharmaceutical nanotechnology2022

Peculiarities of Bioaccumulation and Toxic Effects Produced by Nanoparticles of Molybdenum (VI) Oxide under Multiple Oral Exposure of Rats: Examination and Comparative Assessment.

Nina Vladimirovna Zaitseva, Marina Aleksandrovna Zemlyanova, Mark Sergeevich Stepankov, Anna Mikhailovna Ignatova, Olga Vasilievna Pustovalova, Alyona Evgenievna Nikolaeva

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pharmaceutical nanotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nina Vladimirovna ZaitsevaDepartment of Biochemical and Cytogenetics Diagnostics, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, Russia.ORCID 0000-0003-2356-1145
Marina Aleksandrovna ZemlyanovaDepartment of Biochemical and Cytogenetics Diagnostics, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, Russia.ORCID 0000-0002-8013-9613
Mark Sergeevich StepankovDepartment of Biochemical and Cytogenetics Diagnostics, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, Russia.ORCID 0000-0002-7226-7682
Anna Mikhailovna IgnatovaDepartment of Biochemical and Cytogenetics Diagnostics, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, Russia.ORCID 0000-0001-9075-3257
Olga Vasilievna PustovalovaDepartment of Biochemical and Cytogenetics Diagnostics, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, Russia.ORCID 0000-0002-8050-7674
Alyona Evgenievna NikolaevaDepartment of Biochemical and Cytogenetics Diagnostics, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, Russia.
Federal Scientific Center for Medical and Preventive Health Risk Management Technologies · RUMoscow Power Engineering Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMolybdenum (VI) oxide nanoparticles (MoO

objectiveThe study aims to examine and comparatively assess peculiarities of bioaccumulation and toxic effects produced by MoO NPs under multiple oral introductions.

methodsWe evaluated the sizes of analyzed particles by scanning electronic microscopy; the specific surface area was calculated by the method of Brunauer, Emmett and Taylor; the total pore volume by Barrett, Joyner and Halenda. Rats were exposed as per the scheme introduced by Lim with colleagues. We examined biochemical and hematological blood indicators, molybdenum concentrations, and pathomorphological changes in tissues of various organs 24 hours after the last exposure. The study involved a comparison with effects produced by MoO

resultsThe tested MoO

conclusionMoO

Indexed as

Metal NanoparticlesMolybdenumNanoparticlesOxidesAdministration, OralAnimalsBioaccumulationLiverMaleParticle SizeRatsRats, WistarMolybdenummolybdenum trioxideOxidesmicroparticlesMolybdenum (VI) oxidenanoparticlesoral exposurerats.toxicity

Identifiers

PMID36056843
OpenAlexW4294408852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.